IL6 and metabolic syndrome: Among females, patients with MetS also had significantly higher levels of IL-6 [median (IQR): 1.88 (0.88, 2.79) pg/ml vs. 1.07 (0.50, 2.22) pg/ml; P = 0.023] and hsCRP [median (IQR): 1.03 (0.51, 2.19) mg/dl vs. 0.47 (0.27, 1.09) mg/dl; P < 0.001] than subjects without MetS (Table 2).